Autoradiographic method for measuring the ischemic myocardium at risk: effects of verapamil on infarct size aftr experimental coronary artery occlusion.
Open Access
- 1 October 1980
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 77 (10), 6119-6123
- https://doi.org/10.1073/pnas.77.10.6119
Abstract
Investigation of the efficacy of pharmacologic agents affecting myocardial infarct size after coronary artery occlusion is complicated by the variability of collateral flow among experimental animals which results in variability of infarct size. To overcome this difficulty, we developed an autoradiographic method to delineate the ischemic area at risk of necrosis after coronary artery occlusion and we invetigated the potential protective effect of a calcium antagonist verapamil. The left anterior descending coronary arteries of 25 barbiturate-anesthetized dogs were occluded. Thirty minutes later, highly radioactive human albumin microspheres labeled with 99mTc were injected into the left atrium. One hour after coronary artery occlusion, dogs were randomized to control or treated groups; the latter received a 0.2 mg/kg loading dose and 0.6 mg/kg per hr maintenance dose of verapamil intravenously. Eight hours after coronary artery occlusion, the dogs were killed, the hearts were excised, and the left ventricle was sectioned parallel to the atrioventricular groove; infarct size was determined planimetrically after incubation in triphenyl tetrazolium chloride. The slices were then exposed to high-speed x-ray film with image-enhancing screens. The percentage of left ventricle that was ischemic, as determined by planimetry of autoradiographs, was similar in treated and control animals (36.6 +/- 2.0% compared to 37.3 +/- 2.8%, respectively). Of the ischemic area, 92.0 +/- 4.3% was infarcted in control animals and 70.5 +/- 5.1% was infarcted in treated animals (P < 0.01). Thus, this autoradiographic method using 99mTc-labeled human albumin microspheres is useful in delineating the area of ischemia after coronary artery occlusion and in evaluating the efficacy of pharmacologic agents designed to protect ischemic myocardium. Verapamil, administered 1 hr after coronary artery occlusion, is effective in limiting infarct size.This publication has 15 references indexed in Scilit:
- Pharmacological protection of mitochondrial function in hypoxic heart muscle: Effect of verapamil, propranolol, and methylprednisoloneCardiovascular Research, 1978
- Effect of the calcium antagonist verapamil on necrosis following temporary coronary artery occlusion in dogs.Circulation, 1977
- The Effect of Verapamil on Experimental Myocardial Ischaemia with a Particular Reference to Regional Myocardial Blood Flow and Metabolism*Australian and New Zealand Journal of Medicine, 1977
- Effects of verapamil on infarct size following experimental coronary occlusionCardiovascular Research, 1975
- Macroscopic enzyme-mapping verification of large, homogeneous, experimental myocardial infarcts of predictable size and location in dogsThe Journal of Thoracic and Cardiovascular Surgery, 1975
- Reduction of the size of acute, experimental myocardial infarction by VerapamilBasic Research in Cardiology, 1975
- Myocardial Perfusion Scintigraphy after Intracoronary Injection of 99m Tc-Labeled Human Albumin MicrospheresCirculation, 1972
- Myocardial Perfusion Imaging with Radioactive-Labeled Particles Injected Directly into the Coronary Circulation of Patients with Coronary Artery DiseaseCirculation, 1971
- Feasibility and Hazards of the Intracoronary Injection of Radioactive Serum Albumin Macroaggregates for External Myocardial Perfusion ImagingInvestigative Radiology, 1971
- The direct diagnosis of human myocardial ischemia using 131I-MAA via the selective coronary catheter: Preliminary reportAmerican Heart Journal, 1970